At Mallinckrodt Pharmaceuticals, we continually look for companies and products that align with our strategic vision – to be an innovation-driven specialty pharmaceutical company focused on improving outcomes for patients with severe and critical conditions. Our acquisitions help enhance and expand our diverse product portfolio and growing pipeline. Here you’ll be able to find historical information related to the companies we acquire.